Tempest Therapeutics, Inc. Total Liabilities and Equity
Tempest Therapeutics, Inc. (TPST) had Total Liabilities and Equity of $9.63 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $9.63M.
- 2026-03-31: Liabilities and Equity $10.75M.
- 2025-12-31: Liabilities and Equity $16.93M.
- 2025-09-30: Liabilities and Equity $17.13M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $9.63M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $10.75M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $16.93M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $17.13M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $24.48M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $32.16M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $41.49M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $33.84M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $42.17M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $44.38M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $51.60M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $23.99M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $30.74M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $37.33M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $46.09M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $63.17M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $71.35M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $66.95M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $73.24M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $67.14M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $75.50M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $73.24M 10-Q · filed 2022-05-13 | $31.71M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $22.86M 10-K · filed 2022-03-29 | $43.41M 10-K · filed 2021-03-29 |
| 2020-09-30 | $22.86M 10-Q · filed 2021-11-10 | $48.84M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $57.13M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $68.05M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $74.97M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $58.48M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $68.32M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $74.31M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $84.07M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $49.23M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $55.53M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $63.03M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $19.81M 10-K · filed 2019-04-01 | $72.85M 10-K · filed 2018-03-15 |
| 2017-09-30 | $82.03M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $93.89M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $106.32M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $122.54M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $142.40M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $158.72M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $122.06M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $138.61M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $152.81M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $164.45M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $175.78M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $65.57M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $77.50M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $85.83M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $92.76M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $47.55M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $51.23M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $56.24M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $61.17M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $32.81M 10-K · filed 2014-02-27 | |
| 2012-09-30 | $36.33M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $34.98M 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $4.58M 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |